Cancer gene therapy · 1997
Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Anderegg B, Horstmann M, Kabisch H
Аннотация
Rearrangement of the gene tal-1 leads to transcriptional dysregulation and contributes to the formation of childhood T-cell acute lymphoblastic leukemia. Therefore, we tried to interfere with the transcription of the SIL/tal-1 fusion gene, the most common form of aberrant tal-1, by treatment with antisense oligodeoxynucleotides (ODNs). The potential of two different strategies was investigated, one targeting the cell line specific SIL/tal-1 fusion region, the other using an ODN complementary to tal-1 sequence downstream of the region not affected by any of the known types of tal-1 rearrangement. With both approaches a single-dose application of 3 mumol of ODN led to a significant antiproliferative effect of a about 25-60% in two T-ALL cell lines characterized by the SIL/tal-1 fusion gene. Investigation of the tal-1 mRNA level by reverse transcription-polymerase chain reaction was in concordance with these results: In both cell lines clearly less of the tal-1-specific fragment was generated after incubation with the antisense ODN tal-1 common than in the control experiments with a mismatched ODN or no ODN at all. Neither the antiproliferation antisense effect nor the downregulation of the steady state tal-1 mRNA level was observed in control cell lines bearing wildtype tal-1.
Предметные рубрики MeSH
Basic Helix-Loop-Helix ProteinsCell DivisionDNA-Binding ProteinsDose-Response Relationship, DrugHumansIntracellular Signaling Peptides and ProteinsLeukemia-Lymphoma, Adult T-CellMutationOligonucleotides, AntisenseOncogene Proteins, FusionProteinsProto-Oncogene ProteinsRNA, MessengerRecombinant Fusion ProteinsT-Cell Acute Lymphocytic Leukemia Protein 1Transcription FactorsTumor Cells, Cultured